Concepedia

Miyuki Yoshida

MY

22

Publications

1.2K

Citations

16

H-Index

1995

Active since

Affiliations

Chugai Pharma (United States)(Current)

Shizuoka University

Nihon University

Yamaguchi University

Tokyo University of Marine Science and Technology

Miyuki Yoshida is an author at Chugai Pharma (United States) specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1995–2018

22

Publications

22

Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia

Ken Kaito, Hiroko Otsubo, Noriko Usui et al. · British Journal of Haematology · 2005 · 289 citations · Full text

Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance

Tatsushi Kodama, Toshiyuki Tsukaguchi, Miyuki Yoshida et al. · Cancer Letters · 2014 · 195 citations

, , +9

Alectinib Shows Potent Antitumor Activity against <i>RET</i> -Rearranged Non–Small Cell Lung Cancer

Tatsushi Kodama, Toshiyuki Tsukaguchi, Yasuko Satoh et al. · Molecular Cancer Therapeutics · 2014 · 155 citations · Full text

The Selective Class I PI3K Inhibitor CH5132799 Targets Human Cancers Harboring Oncogenic <i>PIK3CA</i> Mutations

Hiroshi Tanaka, Miyuki Yoshida, Hiromi Tanimura et al. · Clinical Cancer Research · 2011 · 95 citations

Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799

Jun Ohwada, Hirosato Ebiike, Hatsuo Kawada et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 70 citations · Full text

, , +10

Rows per page

1–5 of 22